How to design multi-target drugs

Bibliography

• BROWN D, SUPERTI-FURGA G: Rediscovering the sweet spot in drug discovery. Drug Discov. Today. (2003) 8:1067-1077
   PubMed Web of Science ®Google Scholar
• OVERINGTON JP, AL-LAZIKANI B, HOPKINS AL: How many drug targets are there? Nat. Rev. Drug Discov. (2006) 5:993-996
   PubMed Web of Science ®Google Scholar
• SZUROMI P, VINSON V, MARSHALL E: Rethinking drug discovery. Science. (2004) 303:1795.
   Web of Science ®Google Scholar
• BORISY AA, ELLIOTT PJ, HURST NW et al.: Systematic discovery of multicomponent therapeutics. Proc. Natl. Acad. Sci. USA. (2003) 100:7977-7982
   PubMed Web of Science ®Google Scholar
• DANCEY JE, CHEN HX: Strategies for optimizing combinations of molecularly targeted anticancer agents. Nat. Rev. Drug Discov. (2006) 5:649-659
   PubMed Web of Science ®Google Scholar
• KEITH CT, BORISY AA, STOCKWELL BR: Multicomponent therapeutics for networked systems. Nat. Rev. Drug Discov. (2005) 4:71-78
   PubMed Web of Science ®Google Scholar
• MILLAN MJ: Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol. Therap. (2006) 110:135-370
   PubMed Web of Science ®Google Scholar
• ZIMMERMANN GR, LEHAR J, KEITH CT: Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov. Today. (2007) 12:34-42
   PubMed Web of Science ®Google Scholar
• FITTER S, JAMES R: Deconvolution of a complex target using DNA aptamers. J. Biol. Chem. (2005) 280:34193-34201
   PubMed Web of Science ®Google Scholar
• ROLLINGER JM, LANGER T, STUPPNER H: Strategies for efficient lead structure discovery from natural products. Curr. Med. Chem. (2006)13:1491-1507
   PubMed Web of Science ®Google Scholar
• SHAFIKHANI SH, ENGEL J: Pseudomonas aeruginosa type III-secreted toxin ExoT inhibits host-cell division by targeting cytokinesis at multiple steps. Proc. Natl. Acad. Sci. USA. (2006) 103:15605-15610
   PubMed Web of Science ®Google Scholar
• PAPP B, PAL C, HURST LD: Metabolic network analysis of the causes and evolution of enzyme dispensability in yeast. Nature (2004) 429:661-664
   PubMed Web of Science ®Google Scholar
• PAL C, PAPP B, LERCHER MJ, CSERMELY P, OLIVER SG, HURST LD: Chance and necessity in the evolution of minimal metabolic networks. Nature (2006) 440:667-670
   PubMed Web of Science ®Google Scholar
• KITANO H: A robustness-based approach to systems-oriented drug design. Nat. Rev. Drug Discov. (2007) 6:202-210
   PubMed Web of Science ®Google Scholar
• SHAROM JR, BELLOWS DS, TYERS M: From large networks to small molecules. Curr. Op. Chem. Biol. (2004) 8:81-90
   PubMed Web of Science ®Google Scholar
• FRANTZ S: Drug discovery: Playing dirty. Nature (2005) 437:942-943
   PubMed Web of Science ®Google Scholar
• HUANG S: Rational drug discovery: what can we learn from regulatory networks? Drug Discov. Today. (2002) 7:S163-S169.
   PubMed Web of Science ®Google Scholar
• KAELIN WG Jr.: Gleevec: prototype or outlier? Science STKE (2004) (225), pe12.
   PubMedGoogle Scholar
• MORPHY R, KAY C, RANKOVIC Z: From magic bullets to designed multiple ligands. Drug Discovery Today. (2004) 9:641-651
   PubMed Web of Science ®Google Scholar
• ROGAWSKI MA: Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents – towards an understanding of their favorable tolerability. Amino Acids. (2000) 19:133-149
   PubMed Web of Science ®Google Scholar
• SATHORNSUMETEE S, VREDENBURGH KA, LATTIMORE KP, RICH JN: Malignant glioma drug discovery – targeting protein kinases. Expert. Opin. Drug Discov. (2007) 2:1-17
   PubMed Web of Science ®Google Scholar
• SOTI C, NAGY E, GIRICZ Z, VIGH L, CSERMELY P, FERDINANDY P: Heat shock proteins as emerging therapeutic targets. Br. J. Pharmacol. (2005) 146:769-780
   PubMed Web of Science ®Google Scholar
• SREEDHAR AS, SOTI C, CSERMELY P: Inhibition of Hsp90: a new strategy for inhibiting protein kinases. Biochim. Biophys. Acta (2004) 1697:233-242
   PubMed Web of Science ®Google Scholar
• YOUDIM MBH, BUCCAFUSCO JJ: Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. Trends Pharmacol. Sci. (2005) 26:27-36
   PubMed Web of Science ®Google Scholar
• SHARON J, LIEBMAN MA, WILLIAMS BR: Recombinant polyclonal antibodies for cancer therapy. J. Cell Biochem. (2005) 96:305-313
   PubMed Web of Science ®Google Scholar
• TODOROVSKA A, ROOVERS RC, DOLEZAL O, KORTT AA, HOOGENBOOM HR, HUDSON PJ: Design and application of diabodies, triabodies and tetrabodies for cancer targeting. J. Immunol. Methods. (2001) 248:47-66
   PubMed Web of Science ®Google Scholar
• BARABASI A-L, OLTVAI ZN: Network biology: understanding the cell's functional organization. Nat. Rev. Genet. (2004) 5:101-113
   PubMed Web of Science ®Google Scholar
• BOCCALETTI S, LATORA V, MORENO Y, CHAVEZ M, HWANG D-U: Complex networks: structure and dynamics. Physics Rep. (2006) 424:175-308
   Web of Science ®Google Scholar
• CSERMELY P: Weak links: a universal key for network diversity and stability. Springer Verlag, Heidelberg (2006).
   Google Scholar
• BARABASI A-L, ALBERT R: Emergence of scaling in random networks. Science. (1999) 286:509-512
   PubMed Web of Science ®Google Scholar
• PALLA G, DERENYI I, FARKAS T, VICSEK T: Uncovering the overlapping community structure of complex networks in nature and society. Nature. (2005) 435:814-818
   PubMed Web of Science ®Google Scholar
• WATTS DJ, STOGATZ SH: Collective dynamics of ‘small-world’ networks. Nature. (1998) 393:440-442
   PubMed Web of Science ®Google Scholar
• ARITA M: The metabolic world of Escherichia coli is not small. Proc. Natl. Acad. Sci. USA. (2004) 101:1543-1547
   PubMed Web of Science ®Google Scholar
• TANAKA R, YI TM, DOYLE J: Some protein interaction data do not exhibit power law statistics. FEBS Lett. (2005) 579:5140-5144
   PubMed Web of Science ®Google Scholar
• CHAUDHURI A, CHANT J: Protein-interaction mapping in search of effective drug targets. Bioessays. (2005) 27:958-969
   PubMed Web of Science ®Google Scholar
• TANIGUCHI CM, EMANUELLI B, KAHN CR: Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. (2006) 7:85-96
   PubMed Web of Science ®Google Scholar
• SANTONICO E, CASTAGNOLI L, CESARENI G: Methods to reveal domain networks. Drug Discov. Today. (2005) 10:1111-1117
   PubMed Web of Science ®Google Scholar
• WILSON D, MADERA M, VOGEL C, CHOTHIA C, GOUGH J: The SUPERFAMILY database in 2007: families and functions. Nucleic Acids Res. (2007) 35:D308-D313.
   PubMed Web of Science ®Google Scholar
• KELL DB: Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Discov. Today. (2006) 11:1085-1092
   PubMed Web of Science ®Google Scholar
• MICHAELIS ML, SEYB KI, ANSAR S: Cytoskeletal integrity as a drug target. Curr. Alzheimer Res. (2005) 2:227-229
   PubMedGoogle Scholar
• VON MERING C, KRAUSE R, SNEL B et al.: Comparative assessment of large-scale data sets of protein-protein interactions. Nature (2002) 417:399-403
   PubMed Web of Science ®Google Scholar
• SHEN J, ZHANG J, LUO X et al.: Predicting protein-protein interactions based only on sequences information. Proc. Natl. Acad. Sci. USA. (2007) 104:4337-4341
   PubMed Web of Science ®Google Scholar
• KIM PM, LU LJ, XIA Y, GERSTEIN MB: Relating three-dimensional structures to protein networks provides evolutionary insights. Science (2006) 314:1938-1941
   PubMed Web of Science ®Google Scholar
• LIPTON SA: Turning down, but not off. Neuroprotection requires a paradigm shift in drug development. Nature (2004) 428:473.
   PubMedGoogle Scholar
• CHENG Y, LEGALL T, OLDFIELD CJ et al.: Rational drug design via intrinsically disordered protein. Trends Biotechnol. (2006) 24:435-442
   PubMed Web of Science ®Google Scholar
• CSERMELY P: Strong links are important, but weak links stabilize them. Trends Biochem. Sci. (2004) 29:331-334
   PubMed Web of Science ®Google Scholar
• AMES BN: Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc. Natl. Acad. Sci. USA. (2006) 103:17589-17594
   PubMed Web of Science ®Google Scholar
• KLEIN P, PAWSON T, TYERS M: Mathematical modeling suggests cooperative interactions between a disordered polyvalent ligand and a single receptor site. Curr Biol. (2003) 13:1669-1678
   PubMed Web of Science ®Google Scholar
• NASH P, TANG X, ORLICKY S, et al.: Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature (2001) 414:514-521
   PubMed Web of Science ®Google Scholar
• KIRKWOOD TBL, KOWALD A: The network theory of aging. Exp. Gerontol. (1997) 32:395-399
   PubMed Web of Science ®Google Scholar
• ALBERT R, JEONG H, BARABASI A-L: Attack and error tolerance of complex networks. Nature (2000) 406:378-382
   PubMed Web of Science ®Google Scholar
• COHEN R, EREZ K, BEN-AVRAHAM, D, HAVLIN, S: Resilience of the Internet to random breakdowns. Phys. Rev. Lett. (2000) 85:4626-4628
   PubMed Web of Science ®Google Scholar
• HOLME P, KIM BJ, YOON, CN, HAN, SK: Attack vulnerability of complex networks. Phys. Rev. E (2002) 65:056109.
   Web of Science ®Google Scholar
• FREEMAN LC: A set of measuring centrality based on betweenness. Sociometry (1977) 40:35-41
   Google Scholar
• AGOSTON V, CSERMELY P, PONGOR S: Multiple hits confuse complex systems: a genetic network as an example. Phys. Rev. E (2005) 71:051909.
   Google Scholar
• LATORA V, MARCHIORI, M: Efficient behavior of small-world networks. Phys. Rev. Lett. (2001) 87:198701.
   PubMed Web of Science ®Google Scholar
• LATORA V, MARCHIORI, M: Vulnerability and protection of infrastructure networks. Phys. Rev. E. (2005) 71:015103.
   PubMed Web of Science ®Google Scholar
• DALL'ASTA L, BARRAT A, BARTHéLEMY M, VESPIGNANI A. Vulnerability of weighted networks. J. Stat. Mech. (2006) P04006.
   Google Scholar
• MOTTER AE, NISHIKAWA T, LAI Y: Range-based attack on links in scale-free networks: Are long-range links responsible for the small-world phenomenon? Phys. Rev. E. (2002) 66:065103.
   Google Scholar
• CASCANTE M, BOROS LG, COMIN-ANDUIX B, DE ATAURI P, CENTELLES JJ, LEE PWN: Metabolic control analysis in drug discovery and disease. Nat. Biotechnol. (2002) 20:243-249
   PubMed Web of Science ®Google Scholar
• CORNISH-BOWDEN A CARDENAS ML: Metabolic analysis in drug design. C. R. Biol. (2003) 326:509-515
   PubMed Web of Science ®Google Scholar
• DUARTE NC, BECKER SA, JAMSHIDI N et al.: Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. USA. (2007) 104:1777-1782
   PubMed Web of Science ®Google Scholar
• BERGMANN S, IHMELS J, BARKAI N: Similarities and differences in genome-wide expression data of six organisms. PLoS Biology. (2004) 2:85-93 (E9).
   Web of Science ®Google Scholar
• STUART JM, SEGAL E, KOLLER D, KIM SK: A gene-coexpression network for global discovery of conserved genetic modules. Science (2003) 302:249-255
   PubMed Web of Science ®Google Scholar
• ARCHAKOV AI, GOVORUN VM, DUBANOV AV et al.: Protein-protein interactions as a target for drugs in proteomics. Proteomics. (2003) 3:380-391
   PubMed Web of Science ®Google Scholar
• AOYAMA T, SUZUKI Y, ICHIKAWA H: Neural networks applied to quantitative structure-activity relationship analysis. J. Med. Chem. (1990) 33:2583-2590
   PubMed Web of Science ®Google Scholar
• CSERMELY P, AGOSTON V, PONGOR S: The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol. Sci. (2005) 26:187-182
   Google Scholar
• HORNBERG JJ, BRUGGEMAN FJ, WESTERHOFF HV, LANKELMA J: Cancer: a Systems Biology disease. Biosystems. (2006) 83:81-90
   PubMed Web of Science ®Google Scholar
• PALOP JJ, CHIN J, MUCKE L: A network dysfunction perspective on neurodegenerative diseases. Nature. (2006) 443:768-773
   PubMed Web of Science ®Google Scholar
• CSERMELY P, SOTI C: Aging cellular networks: chaperones as major participants. Exp. Gerontol. (2007) 42:113-119
   PubMed Web of Science ®Google Scholar
• GARDNER TS, DI BERNARDO D, LORENZ D, COLLINS JJ: Inferring genetic networks and identifying compound mode of action via expression profiling. Science (2003) 301:102-105
   PubMed Web of Science ®Google Scholar
• GIAEVER G, FLAHERTY P, KUMM J et al.: Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc. Natl. Acad. Sci. USA. (2004) 101:793-798
   PubMed Web of Science ®Google Scholar
• LUM PY, ARMOUR CD, STEPANIATS SB, et al.: Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell (2004) 116:121-137
   PubMed Web of Science ®Google Scholar
• PARSONS AB, LOPEZ A, GIVONI IE, et al.: Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell (2006) 126:611-625
   PubMed Web of Science ®Google Scholar
• IN VIVO PHARMACOLOGY TRAINING GROUP: The fall and rise of in vivo pharmacology. Trends Pharmacol. (2002) 23:13-18
   PubMed Web of Science ®Google Scholar
• GOLDBERGER AL, AMARAL LAN, HAUSDORF JM, IVANOV PC, PENG C-K, STANLEY HE: Fractal dynamics in physiology: alterations with disease and aging. Proc. Natl. Acad. Sci. USA. (2002) 99:2466-2472
   PubMed Web of Science ®Google Scholar
• SZALAY M, KOVACS IA, KORCSMAROS T, BODE C, CSERMELY P: Stress-induced rearrangements of cellular networks: consequences for protection and drug design. FEBS Lett. in press, arxiv.org/q-bio.MN/0702006.
   Google Scholar
• HALLEN K, BJORKEGREN J, TEGNER J: Detection of compound mode of action by computational integration of whole-genome measurements and genetic perturbations. BMC Bioinformatics. (2006) 7:51.
   PubMedGoogle Scholar
• KHOLODENKO BN, KIYATKIN A, BRUGGEMAN FJ, SONTAG E, WESTERHOFF HV, HOEK JB: Untangling the wires: A strategy to trace functional interactions in signaling and gene networks. Proc. Natl. Acad. Sci. USA. (2002) 99:12841-12846
   PubMed Web of Science ®Google Scholar
• TEGNÉR J, YEUNG MK, HASTY J, COLLINS JJ: Reverse engineering gene networks: integrating genetic perturbations with dynamical modeling. Proc. Natl. Acad. Sci. USA. (2003) 100:5944-5949
   PubMed Web of Science ®Google Scholar